1 / 22

Acute Kidney Injury after Cardiopulmonary Bypass

Acute Kidney Injury after Cardiopulmonary Bypass. Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine Cardiac Intensive Care Co-Director, Center for Acute Care Nephrology The Heart Institute Cincinnati Children’s Hospital Medical Center.

charde-deleon
Download Presentation

Acute Kidney Injury after Cardiopulmonary Bypass

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Kidney Injury after Cardiopulmonary Bypass Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine Cardiac Intensive Care Co-Director, Center for Acute Care Nephrology The Heart Institute Cincinnati Children’s Hospital Medical Center

  2. HEART KIDNEY

  3. Why Study AKI after Cardiac Surgery? • Over a million adults and 25,000 children undergo cardiac surgery with CPB in the US each year • Acute Kidney Injury (AKI) occurs in 30-40% of adult and pediatric patients after CPB • Pediatric patients- particularly infants- may be especially vulnerable • Planned period of renal ischemia • Pediatric patients free of other “co-morbidities” that may confound therapies

  4. Impact of CS-AKI • Independently associated with: • Increased mortality • Increased length of postoperative ventilation • Longer hospital and ICU lengths of stay • Increased hospital costs • Worse ventricular function on discharge echo • Lower long-term quality of life

  5. 430 infants <90d undergoing CPB-- 52% developed postoperative AKI

  6. Long-term effects of CS-AKI in pediatrics Growth (height) impairment Increased health care utilization Trend towards higher long-term mortality Unknown long-term risk of CKD Brown et al, Ann Thorac Surg, 2010;90:1142-1149 Morgan et al, J Pediatr, 2012 Aug 7 [Epub]

  7. Mechanisms of Injury during CPB Ischemia/reperfusion injury Inflammation Oxidative stress RBC injury Coagulopathy Loss of pulsatile flow Microembolism Hypothermia Altered hemodynamics

  8. Mechanisms of AKI Devarajan JASN 17:1503-20, 2006

  9. Biochemistry of AKI Devarajan JASN 17:1503-20, 2006

  10. Risk Factors for CS-AKI

  11. Risk Factors for CS-AKI

  12. Risk Factors for CS-AKI

  13. Defining the “At Risk Population” Several Scoring systems have been developed/studied: CICSS (Continuing Improvement in Cardiac Surgery Study) Cleveland Clinic STS Bedside Risk MCSPI (Multicenter study of perioperative ischemia) AKICS (AKI after Cardiac Surgery) NNECDSG (Northern New England Cardiovascular Disease Study Group) Reported AUC’s 0.72-0.84

  14. Huen and Parikh, Ann Thorac Surg 2012;93: 337-47

  15. Genetics and AKI Search for genetic polymorphisms the predispose to AKI Majority are SNPs associated with gene products that contribute to: Proinflammatory state Increased response to oxidative stress Impaired renal vascular responsiveness

  16. Genetics and AKI 1671 patients Aorto-coronary surgery Highest AKI risk (4X greater) with combination AGT 842G + IL-6 -572

  17. Potential Areas for Intervention Apoptosis inhibitors

  18. Potential Areas for Intervention Vasodilators ATP donors NOS inhibitors Iron chelators Iron Ca channel blockers Apoptosis inhibitors Anti-oxidants

  19. Currently Available Therapies Mariscalco et al. Ann Thorac Surg 2011; 92: 1539-47

  20. What’s on the Horizon Modification of diagnostic criteria for AKI Development of reliable tools to predict who will develop AKI and for early rapid diagnosis Therapeutic trials

More Related